Sponsored Links
RPT-BRIEF-Emergent Biosolutions to expand clinical trial of TRU-016 and rituximab
April 5 (Reuters) - April 5 (Reuters) - Emergent Biosolutions Inc : * To expand front line CLL clinical trial of TRU-016 and rituximab based on strong patient enrollment and encouraging early clinical data * Source text for Eikon * Further company coverage
- Tweet this
- Link this
- Share this
- Digg this
- Reprints



Follow Reuters